OSTEOFIX FLAVIN IPRIVAL OSTEON

Dose: 200 mg
Single Dose: 200 (200)
Frequency: 8 hourly
Route: PO
Instructions:

Dose:
Single Dose:
Frequency:
Route:
Instructions: Not recommended in this age group

Dose:
Single Dose:
Frequency:
Route:
Instructions: Not recommended in this age group

. It is of Synthetic origin and belongs to Isoflavanoid. It belongs to Bone Metabolism pharmacological group.The Molecular Weight of Ipriflavone is 280.30.

Ipriflavone is contraindicated in conditions like GI ulceration.

The severe or irreversible adverse effects of Ipriflavone, which give rise to further complications include Eelvated hepatic enzymes, Hyperbilirubinemia.Ipriflavone produces potentially life-threatening effects which include Lymphocytopenia. which are responsible for the discontinuation of Ipriflavone therapy.The symptomatic adverse reactions produced by Ipriflavone are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, VertigoX, GI disturbance, dizziness.

'Ipriflavone is primarily indicated in conditions like Hyperparathyroidism, Osteoporosis, Paget''s disease of bone.'

No data regarding the interactions of Ipriflavone was found.

Drug should not be given to Neonates, and Pregnant Mothers.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Ipriflavone should be cautiously administered to patients with serious hepatic or renal lesions and hematological disturbances. There in no information about the safety in children. If administered to patient under therapy with coumarin-anticoagulants ipriflavone causes an increase in their activity, therefore a monitor of the coagulation parameters and if necessary, an adjustment of the anticoagulant drug dosage are advisable.